Vaccines for Tropical Diseases
A vaccine is a suspension of whole or fractionated bacteria or viruses that are rendered non-pathogenic. Vaccination has been extremely effective in preventing various serious infections that were once fatal and now have been eliminated. However, these infections still occur in parts of the under-developed and developing nations. Vaccines are frequently unavailable in developing countries. Each year, millions of people die from drug-treatable vaccine-preventable diseases. Furthermore, successful vaccines have yet to be developed for major global diseases such as tuberculosis. In addition, technologies that are used to develop and manufacture vaccines are often outdated and are not easily adaptable for rapidly responding to disease outbreaks, such as influenza.
- Hookworm vaccines
- Schistosomiasis vaccines
- Cysticercosis vaccines
- Echinococcosis vaccines
- Enteric protozoa vaccines
- Vaccines for Leishmaniasis
- Anthelminthic Vaccines
- Kinetoplastid Vaccines
Related Conference of Vaccines for Tropical Diseases
11th International Conference on Infectious and Rare Diseases
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
20th World Conference on Infectious Diseases, Prevention and Control
8th Annual Congress on Bacterial, Viral and Infectious Diseases
17th Global Conference on Nephrology and Infectious Diseases
6th International Conference on Microbiology and Infectious Diseases
7th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes
10th International Conference on Infectious Diseases: Control and Prevention
13th International Conference on Infectious Diseases, Bacteriology and Antibiotics
6th World Congress on Tuberculosis, Lung Infections, and Respiratory Care
Vaccines for Tropical Diseases Conference Speakers
Recommended Sessions
- Animal Diseases
- Anti-Microbial Resistance in NTDs
- Current Advancements in NTD
- Emerging Neglected Tropical Diseases
- Global NTD Epidemiology and Challenges
- Neglected Tropical Diseases in Clinical Research
- Orphan Drugs
- POC Treatment in NTD
- Rare Diseases
- Socio-economic impact of NTD
- Tropical Bacterial Diseases
- Tropical Parasitic Diseases
- Tropical Protozoan Diseases
- Tropical Viral Diseases
- Tropical Zoonotic Diseases
- Vaccines for Tropical Diseases
- Water, Sanitation and Hygiene
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- A prospective study of dermatological infections - Emerging Infectious Diseases 2025 (Canada)
- Advancements in Vaccines and Therapeutic - Infectious Diseases 2026 (France)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antigen-Antibody Reactions - Infectious Diseases 2026 (France)
- Antimicrobial Resistance - Emerging Infectious Diseases 2025 (Canada)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial Infections and Antimicrobial Resistance (AMR) - Euro Infectious Diseases 2026 (UK)
- Bacterial Infections and Diseases - Infectious Diseases 2026 (France)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Biofertilizers - Infectious Diseases 2026 (France)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Cardiovascular Diseases and Disorders - Emerging Infectious Diseases 2025 (Canada)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Changing Patterns of Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Climate Change, Urbanization, and Infectious Disease Spread - Euro Infectious Diseases 2026 (UK)
- Clinical and Case Reports - INFECTIOUS DISEASES-2026 (France)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2026 (France)
- COVID-19 - Infectious Diseases 2026 (France)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dental diseases & Infections - Emerging Infectious Diseases 2025 (Canada)
- Diabetes and Wound Care - Emerging Infectious Diseases 2025 (Canada)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2025 (Canada)
- Diagnostics and Molecular Tools in Infectious Disease - Euro Infectious Diseases 2026 (UK)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Epidemiology - Infection Prevention 2025 (UK)
- Epidemiology - INFECTIOUS DISEASES-2026 (France)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2025 (Canada)
- Fungal Infections - Infectious Diseases 2026 (France)
- Fungal Infections: Diagnosis and Emerging Threats - Euro Infectious Diseases 2026 (UK)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Gene Expression - Infectious Diseases 2026 (France)
- Global Climatic Change and Emerging Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Emerging Infectious Diseases 2025 (Canada)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- HIV/AIDS and Sexually Transmitted Infections (STIs) - Euro Infectious Diseases 2026 (UK)
- Human Monkeypox: An Emerging Zoonosis - Emerging Infectious Diseases 2025 (Canada)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control and Hospital-Acquired Infections (HAIs) - Euro Infectious Diseases 2026 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases and Cancer - Infectious Diseases 2026 (France)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2026 (France)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Mutations - Infectious Diseases 2026 (France)
- Neuro Infections - Infection Prevention 2025 (UK)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2026 (France)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Nosocomial Infections and Their Control Strategies - Emerging Infectious Diseases 2025 (Canada)
- One Health and Emerging Global Threats - Euro Infectious Diseases 2026 (UK)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2025 (Canada)
- Parasitic Infections - Infectious Diseases 2026 (France)
- Parasitic Infections and Neglected Tropical Diseases (NTDs) - Euro Infectious Diseases 2026 (UK)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Pediatric Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Pediatric Infectious Diseases and Immunization Programs - Euro Infectious Diseases 2026 (UK)
- Perspectives on Gastrointestinal Infections - Emerging Infectious Diseases 2025 (Canada)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Prion Diseases - Infectious Diseases 2026 (France)
- Probiotics and Prebiotics - Infectious Diseases 2026 (France)
- Probiotics and Prebiotics - Infectious Diseases 2026 (France)
- Public Health - STD-HIV AIDS-2025 (USA)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2025 (Canada)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2026 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Respiratory Tract Infections: Viral and Bacterial Perspectives - Euro Infectious Diseases 2026 (UK)
- SARS and MERS: Recent Insights into Emerging Coronaviruses - Emerging Infectious Diseases 2025 (Canada)
- Sepsis and Critical Infections in Clinical Practice - Euro Infectious Diseases 2026 (UK)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases (STDs) and Infections (STIs) - Infectious Diseases 2026 (France)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2025 (Canada)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2025 (Canada)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Tuberculosis and Mycobacterial Diseases - Euro Infectious Diseases 2026 (UK)
- Vaccine Research and Development - Euro Infectious Diseases 2026 (UK)
- Vaccines and Immunization - Emerging Infectious Diseases 2025 (Canada)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2026 (France)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2025 (Canada)
- Veterinary Diseases - INFECTIOUS DISEASES-2026 (France)
- Veterinary Infectious Diseases - Infectious Diseases 2026 (France)
- Viral Infections and Diseases - Infectious Diseases 2026 (France)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)
- Viral Infections: Trends, Variants, and Global Impact - Euro Infectious Diseases 2026 (UK)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Zoonotic and Vector-Borne Diseases - Euro Infectious Diseases 2026 (UK)